| 发明名称 |
Antistoffer mot human MCP-1 |
| 摘要 |
MCP-1 binding molecules are provided comprising at least one immunoglobulin heavy chain variable domain (VH) comprising hypervariable regions CDR1, CDR2 and CDR3 of sequence as defined, for use in the treatment of MCP-1 or eotaxin-mediated diseases or disorders. |
| 申请公布号 |
NO20026063(D0) |
申请公布日期 |
2002.12.17 |
| 申请号 |
NO20020006063 |
申请日期 |
2002.12.17 |
| 申请人 |
NOVARTIS AG |
发明人 |
HIESTAND, PETER;HOFSTETTER, HANS;PAYNE, TREVOR GLYN;URFER, ROMAN;PADOVA, FRANCO E DI |
| 分类号 |
C12N15/09;A61K39/395;A61P1/00;A61P3/10;A61P9/10;A61P11/00;A61P11/02;A61P11/06;A61P17/00;A61P19/02;A61P29/00;A61P35/00;A61P37/02;A61P37/06;A61P43/00;C07K16/18;C07K16/24;C12P21/02;(IPC1-7):C07K |
主分类号 |
C12N15/09 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
